By Frank Esposito, Plastics News Staff
Minneapolis, Minnesota -- Bioplastics feedstock maker BioAmber Inc. hopes to raise as much as $150 million in an initial public offering.
Minneapolis-based BioAmber filed the offering 14 Nov with the Securities and Exchange Commission. No date has been set for the proposed IPO. Since late 2008, BioAmber has raised about $75 million in funding from investors including Mitsui & Co. Ltd. of Tokyo, Soffinova Partners of Paris and Cliffton Group of Montreal.
BioAmber produces bio-based succinic acid, which can be used to make the polyurethane raw material butanediol, and is also a plasticiser feedstock. To date, the firm has made only sample lots of its material for potential customers, officials said in the filing. In the year ended 30 June, BioAmber lost about $8 million on sales of just under $1 million, most of which came from licensing.
But the firm has big plans, including the building of a 75-million-pound-capacity (30 kilotonnes) plant adjacent to a Lanxess AG facility in Sarnia, Ontario. That site is set to open in 2013. Longer-term, BioAmber plans to build a second plant in Thailand through a partnership with Mitsui. A third plant may be built in the US or Brazil, officials said in the filing.
That new capacity will be needed, since officials said in the filing that BioAmber has supply agreements in place for about 185 million pounds of its products over the next five years. They added their materials can be competitive with conventional products even if the price of oil drops to $35 per barrel. The price of oil was near $101.50 in late trading 16 Nov.